Findings opposed to use of Azithromycin+Hydroxychloroquine as COVID-19 intervention
-
Hazard ratio for in-hospital mortality amongst hospitalized patients in New York City were not significantly different for those given Azithromycin+Hydroxychloroquine
-
Odds of cardiac arrest were higher in hospitalized patients in NYC given Azithromycin+Hydroxychloroquine
-
Odds of abnormal ECG findings were higher in hospitalized patients in NYC given Azithromycin+Hydroxychloroquine
-
From multinational registry of patients hospitalized between 12/20/19 and 4/14/20, individuals treated with AZM+HCQ had a higher risk of in-hospital mortality compared to an untreated control group
-
From multinational registry of patients hospitalized between 12/20/19 and 4/14/20, individuals treated with AZM+HCQ had a higher risk of clinically significant ventricular arrhythmia compared to an untreated control group
0
1
Tags
SARS-CoV-2 (COVID-19)
Biomedical Sciences
Related
Findings opposed to use of Azithromycin+Hydroxychloroquine as COVID-19 intervention
Findings in favor of treating COVID-19 infections with hydroxychloroquine (HCQ) + azithromycin (AZM)
Findings indicate no significant difference in comparison to standard care of treating COVID-19 infections with hydroxychloroquine + azithromycin
Learn After
Hazard ratio for time to in-hospital mortality amongst hospitalized COVID-19 patients in New York City were not significantly different for those given Azithromycin, Hydroxychloroquine, or a combination
Proportion of abnormal ECG findings in hospitalized COVID-19 patients in New York City were higher amongst those who received Azithromycin+Hydroxychloroquine and Hydroxychloroquine
Hazard ratios for ventricular arrhythmia among COVID-19 patients given different antimalarial and macrolide therapies from multinational registry of patients hospitalized between 12/20/19 and 4/14/20
Hazard ratios for in-hospital mortality among COVID-19 patients given different antimalarial and macrolide therapies from multinational registry of patients hospitalized between 12/20/19 and 4/14/20
Association of Treatment With Hydroxychloroquine or Azithromycin With In-Hospital Mortality in Patients With COVID-19 in New York State
Findings from a Systematic Review and Meta-Analysis on the Effect of Hydroxychloroquine With or Without Azithromycin on the Mortality of COVID-19 Patients